Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework
May 24, 2024 08:37 ET
|
Stereotaxis, Inc.
Stereotaxis has received CE Mark recertification under the EU’s new Medical Device Regulation (MDR) regulatory framework for all available devices.
Rhino Health and Medinexo Partner to Expand Data Diversity in Therapeutic Development
May 22, 2024 15:35 ET
|
Rhino Health
Rhino Health and Medinexo are partnering to provide federated access to a global network of hospitals to accelerate biopharma research.
Medical Polymer Market worth $60.5 billion by 2029 Globally, at a CAGR of 8.0%, says MarketsandMarkets™
May 21, 2024 04:00 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 21, 2024 (GLOBE NEWSWIRE) -- The Global Medical Polymer Market is projected to grow from USD 41.1 billion in 2024, and it is projected to reach USD 60.5 billion by 2029, at a CAGR of...
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
May 15, 2024 07:32 ET
|
Neuronetics
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Russia Medical Consumables Market Booms to $118.7 Million by 2027: Rising Healthcare Expenditure and Chronic Disease Burden Drive Growth: Ken Research
May 14, 2024 06:19 ET
|
Ken Research
Gurugram, India, May 14, 2024 (GLOBE NEWSWIRE) -- Bandage up for a bonanza! Russia medical consumables market is poised for significant growth, with a projected market size of $118.7 million by...
Kardium visar på utökat kliniskt användningsområde för sin CHS™-coatade Globe-kateter
May 14, 2024 03:54 ET
|
Corline Biomedical AB
Kardium Inc. – en av Corlines kunder, som använder CHS™-ytan på sin Globe-kateter för behandling av hjärtarytmi – meddelar att bolaget med sitt Globe-system framgångsrikt behandlat patienter som lider...
CytoSorbents Reports First Quarter 2024 Results
May 09, 2024 16:17 ET
|
CytoSorbents
CytoSorbents Reports First Quarter 2024 Results
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
May 09, 2024 12:00 ET
|
R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)
May 06, 2024 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
May 01, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...